Brief: Finch Therapeutics Reports Second Quarter 2021 Financial Results And Provides Business Update
Aug 10 (Reuters) - Finch Therapeutics Group Inc FNCH.O :
* FINCH THERAPEUTICS REPORTS SECOND QUARTER 2021 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
* FINCH THERAPEUTICS - EXPECTS CASH AND CASH EQUIVALENTS ON
HAND
AT JUNE 30, 2021 WILL BE SUFFICIENT TO FUND OPERATING EXPENSES
AND CAPEX INTO MID-202
* FINCH THERAPEUTICS GROUP INC - QTRLY LOSS PER SHARE $0.32
* FINCH THERAPEUTICS GROUP INC - QTRLY REVENUE $2.8 MILLION
VERSUS
$2.3 MILLION
Source text for Eikon: ID:nGNX2LW1Jy
Further company coverage: FNCH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Finch Therapeutics
See all newsFinch wins US jury trial against Ferring over fecal-transplant patents
Brief: Finch Therapeutics Group Received A Notice From Nasdaq Acknowledging Fact That Co Does Not Meet Requirements Of Rules On April 2
Brief: Finch Therapeutics Got Letter From Nasdaq That Co Has Regained Compliance With Nasdaq’s Listing Rule 5450(A)(1)
U.S. STOCKS ON THE MOVE-Gold miners, ImmunoGen, Oracle
U.S. STOCKS ON THE MOVE-Teekay, gold miners, Oil-Dri Corp